Skip to main content
HR 3172 115th Congress House Health Drug therapy Health technology, devices, supplies Home and outpatient care Immunology and vaccination Medicare

Medicare IVIG Demonstration Extension Act of 2017

Introduced: July 10, 2017 See on congress.gov
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 20, 2017
Referred to the Subcommittee on Health.
Jul 14, 2017
Referred to the Subcommittee on Health.
Jul 10, 2017
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 10, 2017
Introduced in House
 Plain-English summary Congressional Research Service

Medicare IVIG Demonstration Extension Act of 2017

This bill amends the Medicare IVIG Access and Strengthening Medicare and Repaying Taxpayers Act of 2012 to extend the Medicare Intravenous Immune Globulin (IVIG) demonstration project through 2020, subject to the availability of funds. (This demonstration project provides for bundled Medicare payments with respect to certain items and services that are necessary to administer IVIG in the home.) A Medicare beneficiary who is enrolled in the project on September 30, 2017, shall be automatically reenrolled, subject to an existing cap on project participants.

What's happening now July 20, 2017

Referred to the Subcommittee on Health.

 Committees of jurisdiction 4